Apyx Medical Corporation
APYX
$1.99
-$0.03-1.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.14% | -6.27% | -8.11% | -3.49% | 3.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.14% | -6.27% | -8.11% | -3.49% | 3.36% |
| Cost of Revenue | -4.47% | -0.57% | 0.82% | 11.55% | 12.64% |
| Gross Profit | -5.55% | -9.52% | -13.03% | -11.33% | -1.62% |
| SG&A Expenses | -21.58% | -16.11% | -10.66% | -5.36% | -0.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.86% | -12.38% | -7.40% | -0.73% | 3.91% |
| Operating Income | 45.48% | 27.08% | 5.54% | -6.10% | -5.11% |
| Income Before Tax | 40.40% | 13.58% | -9.52% | -60.11% | -55.36% |
| Income Tax Expenses | 292.97% | 321.43% | 110.36% | 110.56% | 93.60% |
| Earnings from Continuing Operations | 39.27% | 12.08% | -24.98% | -86.54% | -73.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -68.22% | 1.96% | -29.93% | -39.71% | -11.57% |
| Net Income | 39.16% | 12.14% | -25.38% | -87.67% | -74.14% |
| EBIT | 45.48% | 27.08% | 5.54% | -6.10% | -5.11% |
| EBITDA | 46.40% | 27.61% | 5.26% | -7.01% | -5.88% |
| EPS Basic | 44.85% | 16.76% | -23.04% | -87.53% | -73.88% |
| Normalized Basic EPS | 39.27% | 16.85% | -9.89% | -22.96% | -19.77% |
| EPS Diluted | 44.85% | 16.76% | -23.04% | -87.53% | -73.88% |
| Normalized Diluted EPS | 39.27% | 16.85% | -9.89% | -22.96% | -19.77% |
| Average Basic Shares Outstanding | 11.36% | 7.00% | 2.64% | 0.10% | 0.15% |
| Average Diluted Shares Outstanding | 11.36% | 7.00% | 2.64% | 0.10% | 0.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |